Institutional investors purchased a net $997.0 thousand shares of SPPI during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 75.03% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MEDICAL STRATEGY GMBH Bought 78.1 Thousand shares of Spectrum Pharmaceuticals ...
CREDIT SUISSE AG Bought 3.9 Thousand shares of Spectrum Pharmaceuticals ...